Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response
Lists
Only you see this
Abstract
Our radiomic-based superpc signature emerges as a putative imaging biomarker for the identification of patients who may derive the most benefit from antiangiogenic therapy, advances the knowledge in the noninvasive characterization of brain tumors, and stresses the role of radiomics as a novel tool for improving decision support in cancer treatment at low cost. Clin Cancer Res; 22(23); 5765-71. ©2016 AACR.
BibTeX
@inproceedings{kickingereder2016large,
author = {Philipp Kickingereder and Michael Götz and John Muschelli and Antje Wick and Ulf Neuberger and Russell T. Shinohara and Martin Sill and Martha Nowosielski and Heinz-Peter Schlemmer and Alexander Radbruch and Wolfgang Wick and Martin Bendszus and Klaus Maier‐Hein and David Bonekamp},
title = {{Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response}},
booktitle = {Clinical},
year = {2016},
doi = {10.1158/1078-0432.ccr-16-0702},
}Loading related content...